Patent assignee · US · COMPANY

LipoScience, Inc.

🏢 View company profile →
36Patents
31Active
36Granted
52Portfolio score

Filing activity: Apr 19, 2000 → Jan 4, 2022 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6576471B2 Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results Emerging Cross-Sectional Technologies 42 Expired
US6518069B1 Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders Emerging Cross-Sectional Technologies 35 Expired
US6617167B2 Method of determining presence and concentration of lipoprotein X in blood plasma and serum Emerging Cross-Sectional Technologies 29 Expired
US7243030B2 Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals Physics 29 Expired
US7790465B2 Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements Emerging Cross-Sectional Technologies 24 Active
US8386187B2 Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same Emerging Cross-Sectional Technologies 12 Active
US8013602B2 NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples Physics 11 Active
US6653140B2 Methods for providing personalized lipoprotein-based risk assessments Emerging Cross-Sectional Technologies 11 Expired
US9361429B2 Multi-parameter diabetes risk evaluations Physics 11 Active
US9792410B2 Multi-parameter diabetes risk evaluations Physics 8 Active
US10388414B2 Multi-parameter diabetes risk evaluations Physics 6 Active
US9435870B2 Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements Physics 5 Active
US9470771B2 NMR measurements of NMR biomarker GlycA Physics 5 Active
US8704521B2 NMR analyzers for clinical evaluation of biosamples Physics 4 Active
US9952232B2 Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter Physics 4 Active
US9483612B2 CHD risk stratification evaluations for subjects with high levels of large HDL-P Physics 4 Active
US10386355B2 CHD risk stratification evaluations for subjects with high levels of large HDL-P Physics 3 Active
US10365339B2 NMR analyzers for clinical evaluation of biosamples Physics 3 Active
US9483611B2 Protective HDL particle number evaluations Physics 2 Active
US9535144B2 NMR quantification of TMAO Physics 2 Active
US9541620B2 NMR quantification of TMAO Physics 2 Active
US10852293B2 NMR measurements of NMR biomarker GlycA Physics 2 Active
US11156621B2 Multi-parameter metabolic vulnerability index evaluations Physics 1 Active
US11231429B2 Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter Physics 1 Active
US9689942B2 Quantitative NMR clinical analyzers with automatic NMR temperature sensitivity compensation that accommodate large ambient operational temperature ranges Physics 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.